Vertex's revenue was $2.96 billion in the second quarter of 2025, beating the consensus forecast by $58 million. Click here ...

Decades of slow-moving research, along with broader failures of the healthcare system, have left millions of people in daily ...

Vertex also announced enrollment completion of the IA cohort of AMPLITUDE, a global Phase 2/3 clinical trial designed to assess the impact of ...

Type 1 Diabetes (T1D) disrupts the flow of daily life. You don’t drive your kids to school because you fear losing control of your car. You plan school and work and socializing around insulin ...

New data suggest antithymocyte globulin, verapamil, and baricitinib might help preserve beta cell function in new-onset type ...

Vertex Pharmaceuticals (VRTX) ended the recent trading session at $381.87, demonstrating a +1.39% change from the preceding day's closing price. The stock outpaced the S&P 500's daily loss of 0.5%. At ...

Finance is fast becoming one of the most high-impact areas for AI adoption. From anomaly detection to predictive compliance, today’s AI-powered tools help turn complexity into easily digestible data ...

That's when Klein decided to give his corporate clients an ultimatum: Migrate your data to our cloud products, or we will no ...

Alibaba Cloud has unveiled the Qwen3-Max model, a suite of agent development tools and cloud infrastructure upgrades to ...

People with new-onset type 1 diabetes can achieve similar improvements in C-peptide levels with a 0.5 mg/kg antithymocyte ...

Ratings for Vertex Pharmaceuticals (NASDAQ: VRTX) were provided by 15 analysts in the past three months, showcasing a mix of ...

Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.